|
06-2030
|
Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetes
Precision administration of anti-thymocyte globulin with or without verapamil in adolescents and young adults with type 1 diabetes
|
|
10-2028
|
Google.org Social Impact Funding: Google AI for Health Education in Diabetes
Google.org Social Impact Funding: Google AI for Health Education in Diabetes
|
|
07-2028
|
Pediatric Endocrinology Fellowship
Pediatric Endocrinology Fellowship
|
|
06-2028
|
Extension for Community Healthcare Outcomes (ECHO) Diabetes for Federally Qualified Health Centers (FQHC)
Extension for Community Healthcare Outcomes (ECHO) Diabetes for Federally Qualified Health Centers (FQHC)
|
|
05-2028
|
Immune Function and the Progression to Type 1 Diabetes
Immune Function and the Progression to Type 1 Diabetes
|
|
11-2027
|
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
|
|
11-2026
|
Implementation of Early Stage T1D Education and Support (ESTES)
Implementation of Early Stage T1D Education and Support (ESTES)
|
|
08-2026
|
Evaluation of the safety, tolerability and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D
Evaluation of the safety, tolerability and general response to Lactobacillus johnsonii N6.2 in children and adolescents with T1D
|
|
07-2026
|
Conceptualization of a Social Determinants of Mental and Behavioral Health (SDMBH) Screening Protocol in the Progression of Autoantibodies to Overt Type 1 Diabetes: An Exploratory Study to Advance Translation and Health Equity Using Technology
Conceptualization of a Social Determinants of Mental and Behavioral Health (SDMBH) Screening Protocol in the Progression of Autoantibodies to Overt Type 1 Diabetes: An Exploratory Study to Advance Translation and Health Equity Using Technology
|
|
06-2026
|
Evaluation of safety, tolerability and immunological responses to Lactobacillus johnsonii N6.2 supplementation in adults with Diabetes type 1
Evaluation of safety, tolerability and immunological responses to Lactobacillus johnsonii N6.2 supplementation in adults with Diabetes type 1
|
|
05-2026
|
Data Coordinating Center for Type 1 Diabetes TrialNet
Data Coordinating Center for Type 1 Diabetes TrialNet
|
|
05-2026
|
TrialNet affiliates reimbursement FY26
TrialNet affiliates reimbursement FY26
|
|
04-2026
|
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes
Development of a Predictive Response Signature to Anti-Thymocyte Globulin in Type 1 Diabetes
|
|
02-2026
|
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
|
|
01-2026
|
Understanding T1D and Insulin-Requiring Diabetes in Federally Qualified Health Centers (FQHC): A National Needs Assessment
Understanding T1D and Insulin-Requiring Diabetes in Federally Qualified Health Centers (FQHC): A National Needs Assessment
|
|
07-2025
|
A 26-week Primary Treatment Phase, with 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza Versus Rapid-acting Insulin Analog Injections, Both in Combination with a Basal Insulin in Pediatric Subjects wi
A 26-week Primary Treatment Phase, with 26-week Extension, Open-label, Randomized Clinical Trial Evaluating the Efficacy and Safety of Afrezza Versus Rapid-acting Insulin Analog Injections, Both in Combination with a Basal Insulin in Pediatric Subjects wi
|
|
06-2025
|
TrialNet affiliates reimbursement FY25
TrialNet affiliates reimbursement FY25
|
|
06-2025
|
Connected Care Pilot Program
Connected Care Pilot Program
|
|
06-2025
|
TrialNet Clinical Center infrastructure support services
TrialNet Clinical Center infrastructure support services
|
|
06-2025
|
TrialNet Clinical Center infrastructure support services
TrialNet Clinical Center infrastructure support services
|
|
05-2025
|
Generation of Islet Specific T Follicular Regulatory Like Cells for Autologous Cell Therapy of Type 1 Diabetes
Generation of Islet Specific T Follicular Regulatory Like Cells for Autologous Cell Therapy of Type 1 Diabetes
|
|
03-2025
|
The T1D Financial Toolkit for Emerging Adults
The T1D Financial Toolkit for Emerging Adults
|
|
03-2025
|
The TEDDY Data Coordinating Center
The TEDDY Data Coordinating Center
|
|
03-2025
|
Increasing Access to Telemedicine Services Through County Extension Offices
Increasing Access to Telemedicine Services Through County Extension Offices
|
|
08-2024
|
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
|
|
06-2024
|
Project ECHO Teleclinics for Rural Providers
Project ECHO Teleclinics for Rural Providers
|
|
06-2024
|
TrialNet Clinic Agreement - Site #0001
TrialNet Clinic Agreement - Site #0001
|
|
06-2024
|
Georgia Center for Diabetes Translation Research Renewal - PILOT
Georgia Center for Diabetes Translation Research Renewal - PILOT
|
|
06-2024
|
Project ECHO T1D: HCT Trial
Project ECHO T1D: HCT Trial
|
|
06-2024
|
Project ECHO T1D: HCT Trial
Project ECHO T1D: HCT Trial
|
|
06-2023
|
UFDI ECHO DIABETES PROPOSAL
UFDI ECHO DIABETES PROPOSAL
|
|
06-2023
|
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
|
|
06-2023
|
TrialNet affiliates reimbursement.
TrialNet affiliates reimbursement.
|
|
05-2023
|
Immune Function and the Progression to Type 1 Diabetes
Immune Function and the Progression to Type 1 Diabetes
|
|
03-2023
|
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TERRY) Study
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TERRY) Study
|
|
11-2022
|
McJunkin Family Foundation Diabetes
McJunkin Family Foundation Diabetes
|
|
11-2022
|
McJunkin Family Foundation Diabetes
McJunkin Family Foundation Diabetes
|
|
09-2022
|
T cell receptor sequencing in type 1 diabetes - biomarker discovery and technology development
T cell receptor sequencing in type 1 diabetes - biomarker discovery and technology development
|
|
06-2022
|
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
Natural History and Mechanisms of Exocrine Pancreatic Dysfunction in Pre-Type 1 Diabetes
|
|
06-2022
|
TrialNet Affiliate Services reimbursement
TrialNet Affiliate Services reimbursement
|
|
06-2021
|
6163-1082-11 TrialNet Affiliate Services
6163-1082-11 TrialNet Affiliate Services
|
|
06-2021
|
6163-1082-11 TrialNet Affiliate Services
6163-1082-11 TrialNet Affiliate Services
|
|
03-2021
|
Emergency Funding to Support Underserved T1D Populations Impacted by the COVID-19 Pandemic
Emergency Funding to Support Underserved T1D Populations Impacted by the COVID-19 Pandemic
|
|
12-2020
|
COVID-19 Telemedicine: Department of Pediatrics
COVID-19 Telemedicine: Department of Pediatrics
|
|
09-2020
|
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
|
|
09-2020
|
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
|
|
07-2020
|
Introducing Continuous Glucose Monitoring Technology at Diagnosis in Pediatric Type 1 Diabetes: A proof of Concept Study.
Introducing Continuous Glucose Monitoring Technology at Diagnosis in Pediatric Type 1 Diabetes: A proof of Concept Study.
|
|
04-2020
|
TrialNet: University of Florida Clinical Center and Network
TrialNet: University of Florida Clinical Center and Network
|
|
01-2020
|
Strategies to Encourage CGM use in Young Children (SENCE)
Strategies to Encourage CGM use in Young Children (SENCE)
|
|
01-2020
|
Strategies to Encourage CGM use in Young Children (SENCE)
Strategies to Encourage CGM use in Young Children (SENCE)
|
|
12-2019
|
Hybrid Closed Loop Insulin Delivery System Data Collection (HYCLO)
Hybrid Closed Loop Insulin Delivery System Data Collection (HYCLO)
|
|
12-2019
|
Hybrid Closed Loop Insulin Delivery System Data Collection (HYCLO)
Hybrid Closed Loop Insulin Delivery System Data Collection (HYCLO)
|
|
11-2019
|
Clinical Trial Planning Grant for Treg Therapy in Type I Diabetes
Clinical Trial Planning Grant for Treg Therapy in Type I Diabetes
|
|
06-2019
|
ECHO Type 1 Diabetes: A Feasibility and Planning Proposal
ECHO Type 1 Diabetes: A Feasibility and Planning Proposal
|
|
06-2019
|
Characterization of T cell Autoreactivity in Type 1 Diabetes
Characterization of T cell Autoreactivity in Type 1 Diabetes
|
|
04-2019
|
Pediatric Endocrine Society Travel Award
Pediatric Endocrine Society Travel Award
|
|
04-2019
|
Pediatric Endocrine Society Travel Award
Pediatric Endocrine Society Travel Award
|
|
03-2019
|
Data Coordinating Center (TEDDY)
Data Coordinating Center (TEDDY)
|
|
03-2019
|
Data Coordinating Center (TEDDY)
Data Coordinating Center (TEDDY)
|
|
03-2019
|
T1d exchange type 1 diabetes network ancilliary study: residual c-peptide in patients with type 1 diabetes
T1d exchange type 1 diabetes network ancilliary study: residual c-peptide in patients with type 1 diabetes
|
|
12-2018
|
Phase II Clinical Trial in New Onset Type 1 Diabetes Patients
Phase II Clinical Trial in New Onset Type 1 Diabetes Patients
|
|
11-2018
|
Young Adult Racial Disparities in Type 1 Diabetes (YARDD)
Young Adult Racial Disparities in Type 1 Diabetes (YARDD)
|
|
11-2018
|
Young Adult Racial Disparities in Type 1 Diabetes (YARDD)
Young Adult Racial Disparities in Type 1 Diabetes (YARDD)
|
|
10-2018
|
Type 1 Diabetes EXercise Initiative (T1-Dexi) Steering Committee
Type 1 Diabetes EXercise Initiative (T1-Dexi) Steering Committee
|
|
10-2018
|
Type 1 Diabetes EXercise Initiative (T1-Dexi) Steering Committee
Type 1 Diabetes EXercise Initiative (T1-Dexi) Steering Committee
|
|
07-2018
|
Low-Dose IL-2 in Established T1D
Low-Dose IL-2 in Established T1D
|
|
07-2018
|
Low-Dose IL-2 in Established T1D
Low-Dose IL-2 in Established T1D
|
|
06-2018
|
TrialNet Affiliate Services FY 17-18
TrialNet Affiliate Services FY 17-18
|
|
06-2018
|
TrialNet Affiliate Services FY 17-18
TrialNet Affiliate Services FY 17-18
|
|
05-2018
|
PES Travel Grant
PES Travel Grant
|
|
05-2018
|
PES Travel Grant
PES Travel Grant
|
|
05-2018
|
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin?) and Pegylated GCSF (Neulasta?) in New Onset Type 1 Diabetes Protocol TN-19
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin?) and Pegylated GCSF (Neulasta?) in New Onset Type 1 Diabetes Protocol TN-19
|
|
03-2018
|
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
|
|
03-2018
|
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study
|
|
02-2018
|
Estimating the Lifetime Costs of Type 1 Diabetes
Estimating the Lifetime Costs of Type 1 Diabetes
|
|
12-2017
|
Pediatric Endocrine Society Travel Award
Pediatric Endocrine Society Travel Award
|
|
12-2017
|
Data Coordinating Center
Data Coordinating Center
|
|
12-2017
|
Data Coordinating Center
Data Coordinating Center
|
|
11-2017
|
A Phase 3B Study to Evaluate the Glucose Response of G-Pen (Glucagon Injection) in Pediatric Patients with Type 1 Diabetes
A Phase 3B Study to Evaluate the Glucose Response of G-Pen (Glucagon Injection) in Pediatric Patients with Type 1 Diabetes
|
|
08-2017
|
Pancreatic Volume in Preclinical Type 1 Diabetes
Pancreatic Volume in Preclinical Type 1 Diabetes
|
|
07-2017
|
Reversing Type 1 Diabetes after it is Established: Follow up, Phase II
Reversing Type 1 Diabetes after it is Established: Follow up, Phase II
|
|
06-2017
|
TrialNet Affiliate Services
TrialNet Affiliate Services
|
|
06-2017
|
TrialNet Affiliate Services
TrialNet Affiliate Services
|
|
03-2017
|
PEDIATRIC ENDOCRINE SOCIETY TRAVEL AWARD
PEDIATRIC ENDOCRINE SOCIETY TRAVEL AWARD
|
|
12-2016
|
Acute effect of a mixed meal with and without insulin on arterial stiffness, a prospective randomized study
Acute effect of a mixed meal with and without insulin on arterial stiffness, a prospective randomized study
|
|
10-2016
|
T1D Exchange Biobank
T1D Exchange Biobank
|
|
10-2016
|
Dissociation of Obesity and insulin sensitivity in 2 rare short stature syndromes
Dissociation of Obesity and insulin sensitivity in 2 rare short stature syndromes
|
|
08-2016
|
Clinical and Translational Science Institute
Clinical and Translational Science Institute
|
|
07-2016
|
Cord Blood Expansion of Regulatory T cells
Cord Blood Expansion of Regulatory T cells
|
|
06-2016
|
Trialnet affiliate services
Trialnet affiliate services
|
|
05-2016
|
Data Coordinating Center
Data Coordinating Center
|
|
05-2016
|
Data Coordinating Center
Data Coordinating Center
|
|
04-2016
|
OPEN-LABEL, SINGLE-ARM, MULTIPLE-DOSE SAFETY, TITRATION, AND, PHARMACOKINETIC TRIAL OF AFREZZA? IN PEDIATRIC PATIENTS AGES,
OPEN-LABEL, SINGLE-ARM, MULTIPLE-DOSE SAFETY, TITRATION, AND, PHARMACOKINETIC TRIAL OF AFREZZA? IN PEDIATRIC PATIENTS AGES,
|
|
03-2016
|
T1D Exchange: BRI Biobank Operations Center
T1D Exchange: BRI Biobank Operations Center
|
|
03-2016
|
T1D Exchange: BRI Biobank Operations Center
T1D Exchange: BRI Biobank Operations Center
|
|
12-2015
|
Non-Invasive Assessment of Pancreatic Volume as a Tool t
Non-Invasive Assessment of Pancreatic Volume as a Tool t
|
|
09-2015
|
CTSA
CTSA
|
|
09-2015
|
CTSA
CTSA
|
|
08-2015
|
Reversing Type 1 Diabetes After it is Established: A Pil
Reversing Type 1 Diabetes After it is Established: A Pil
|
|
04-2015
|
T1D Exchange Type 1 Diabetes Network Study:
T1D Exchange Type 1 Diabetes Network Study:
|
|
02-2015
|
Reversing Type 1 Diabetes After it is Established: A Pil
Reversing Type 1 Diabetes After it is Established: A Pil
|
|
12-2014
|
Cord Blood (UCB) T Cell (Treg)
Cord Blood (UCB) T Cell (Treg)
|
|
02-2014
|
Data Coordinating Center
Data Coordinating Center
|
|
09-2013
|
Cord Blood Therapies for TYpe 1 DIabetes
Cord Blood Therapies for TYpe 1 DIabetes
|
|
09-2013
|
Novel Approaches to the Reversal of Type 1 Diabetes: Sho
Novel Approaches to the Reversal of Type 1 Diabetes: Sho
|
|
09-2013
|
A Phase II multicenter randomized double-blind placebo-c
A Phase II multicenter randomized double-blind placebo-c
|
|
08-2012
|
Nanoparticle-coupled Tregs for the treatment of type 1 d
Nanoparticle-coupled Tregs for the treatment of type 1 d
|
|
03-2011
|
ARRA Equipment Supplement - Short Course G-CSF as Immuno
ARRA Equipment Supplement - Short Course G-CSF as Immuno
|
|
03-2011
|
Short Course G-CSF as Immunomodulatory Therapy for Type
Short Course G-CSF as Immunomodulatory Therapy for Type
|
|
07-2009
|
Islet Regeneration in Animal Models of Type 1 Diabetes w
Islet Regeneration in Animal Models of Type 1 Diabetes w
|
|
04-2009
|
Transfusion of Autologous Umbilical Cord Blood to Revers
Transfusion of Autologous Umbilical Cord Blood to Revers
|
|
07-2008
|
9th Immunology of Diabetes Society Research Symposium
9th Immunology of Diabetes Society Research Symposium
|
|
12-2007
|
Longitudinal Follow-up of Arterial Stiffness and Endothe
Longitudinal Follow-up of Arterial Stiffness and Endothe
|
|
07-2007
|
Pediatric Atorvastatin In Diabetes Intervention Trial
Pediatric Atorvastatin In Diabetes Intervention Trial
|
|
03-2006
|
Endothelial Dysfunction in Children with Type 1 Diabetes
Endothelial Dysfunction in Children with Type 1 Diabetes
|
|
03-2006
|
ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH TYPE I DIABETES
ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH TYPE I DIABETES
|
|
03-2006
|
Travel Grant: 5th Annual American College of Endocrinolo
Travel Grant: 5th Annual American College of Endocrinolo
|
|
03-2005
|
ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH OBESITY AND TYP
ENDOTHELIAL DYSFUNCTION IN CHILDREN WITH OBESITY AND TYP
|